Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-1-28
|
pubmed:abstractText |
Insulin-induced hypoglycemia causes somnolence in rhesus monkeys, a phenomenon usually considered an aspecific consequence of neuroglycopenia. Previous observations from our laboratory have raised the possibility that arginine vasopressin (AVP) may also play a role in this decrease in wakefulness. In the present study we tested this hypothesis by inducing hypoglycemia (approximately 40 mg/dl) in ovariectomized rhesus monkeys by intravenous administration of insulin in the presence of continuous intracerebroventricular infusions of the V1 receptor antagonist [deamino-Pen1, O-Me-Tyr2,Arg8]-vasopressin (180 micrograms/60 microliters per h) or of its vehicle alone (artificial cerebrospinal fluid, 60 microliters/h). Wakefulness was assessed by a scoring system by observers blinded to the experimental protocol. The AVP antagonist significantly attenuated the decrease in wakefulness observed in response to insulin-induced hypoglycemia (p < .03) without increasing blood glucose levels. These and previous findings suggest that the somnolence induced by a moderate degree of hypoglycemia may not entirely be the direct consequence of neuroglycopenia and that AVP may, directly or indirectly, be involved.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arginine Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/argipressin...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0306-4530
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
497-503
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9802124-Animals,
pubmed-meshheading:9802124-Arginine Vasopressin,
pubmed-meshheading:9802124-Blood Glucose,
pubmed-meshheading:9802124-Female,
pubmed-meshheading:9802124-Hypoglycemia,
pubmed-meshheading:9802124-Hypoglycemic Agents,
pubmed-meshheading:9802124-Injections, Intraventricular,
pubmed-meshheading:9802124-Insulin,
pubmed-meshheading:9802124-Macaca mulatta,
pubmed-meshheading:9802124-Ovariectomy,
pubmed-meshheading:9802124-Random Allocation,
pubmed-meshheading:9802124-Receptors, Vasopressin,
pubmed-meshheading:9802124-Sleep Stages,
pubmed-meshheading:9802124-Wakefulness
|
pubmed:year |
1998
|
pubmed:articleTitle |
Mitigation of the somnolence of insulin-induced hypoglycemia by a vasopressin V1 receptor antagonist in the rhesus monkey.
|
pubmed:affiliation |
Laboratory for Neuroendocrinology, University of Texas-Houston Medical School 77225, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|